SCHEMBL5218758

SCHEMBL5218758

Cc1cc(C)cc(-n2cc(-c3ccncn3)cn2)c1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.46
GRM4 Q14833 2/20 0.42
MKNK1 Q9BUB5 6/20 0.40
GRM5 P41594 1/20 0.40
MELK Q14680 2/20 0.38
JAK2 O60674 1/20 0.38
MKNK2 Q9HBH9 1/20 0.37
CYP2D6 P10635 1/20 0.35
GSK3B P49841 2/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
MAP4K4 O95819 1/20 0.34
EGFR P00533 1/20 0.34
FRK P42685 1/20 0.34
MAPK9 P45984 1/20 0.34
CSNK1A1 P48729 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12203764 0.87 PDE10A (0.46) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL14380712 0.83 PDE10A (0.44) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL28245414 0.82 PDE10A (0.46) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL6508391 0.80 MELK (0.56) GRM4MKNK1MELKMKNK2
SCHEMBL5218730 0.80 PDE10A (0.47) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL5215357 0.80 PDE10A (0.47) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL5218142 0.80 PDE10A (0.42) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL8354842 0.80 PDE10A (0.42) PDE10AGRM4MKNK1GRM5MELK
SCHEMBL12410593 0.78 CYP2A6 (0.47) PDE10AGRM4MKNK1GRM5MKNK2
SCHEMBL5216629 0.78 PDE10A (0.44) PDE10AGRM4MKNK1GRM5MELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed
US-9056855-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2015-06-16 US disclosed
US-9056855-B2 Metalloenzyme inhibitor compounds VIAMET PHARMACEUTICALS, INC. (US) 2015-06-16 US disclosed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 US disclosed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 US disclosed
WO-2003051833-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 WO disclosed